[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-354293-105":3,"detail-sidebar-cat-0-en-105":73,"doc-detail-354293-en":122},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":66,"head_meta":68,"extra_data":70,"updated_unix":72},105,"en","ft-mdnnmds-early-detection-of-breast-cancer-using-fine-tuned-multi-deep-neural-networks-with-tcga-and-clinical-image-datasets","FT-MDNNMDs - Early Detection of Breast Cancer Using Fine-Tuned Multi-Deep Neural Networks with TCGA and Clinical Image Datasets","","Breast cancer remains a leading cause of cancer-related mortality among women worldwide, making early and accurate detection essential for improving survival and guiding effective treatment. This study presents FT-MDNNMDs, a fine-tuned Multi-Deep Neural Network system using hierarchical classification to separate normal from cancer and to identify Stage II versus Stage III cancer cases. It combines TCGA data with a private Pakistani clinical image dataset and applies normalization, filtering, and PCA, together with transfer learning and fine-tuning. Results show 99.57% accuracy and improved performance versus baseline machine learning and prior detection models.",{"@graph":14,"@context":65},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ft-mdnnmds-early-detection-of-breast-cancer-using-fine-tuned-multi-deep-neural-networks-with-tcga-and-clinical-image-datasets/354293/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ft-mdnnmds-early-detection-of-breast-cancer-using-fine-tuned-multi-deep-neural-networks-with-tcga-and-clinical-image-datasets/354293.png","ImageObject",300,407,{"name":42,"@type":43},"Grenda","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-10","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59],{"name":60,"@type":61,"acceptedAnswer":62},"How does FT-MDNNMDs perform compared with other methods?","Question",{"text":63,"@type":64},"FT-MDNNMDs reports 99.57% accuracy and stronger metrics such as MCC, F-score, and recall, outperforming conventional machine learning baselines and existing breast cancer detection models by about 1.5% to 3.0% in accuracy.","Answer","https://schema.org",{"og:url":32,"og:type":67,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":69,"canonical":32},"index,follow",{"doc_id":71,"site_id":7},354293,1790887488,{"code":4,"msg":74,"data":75},"success",[76,80,84,88,93,97,102,106,111,114,118],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":77,"show_sort_weight":78,"slug":79},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":81,"show_sort_weight":82,"slug":83},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Exam",70,"exam",{"id":89,"doc_module":4,"doc_module_name":25,"category_name":90,"show_sort_weight":91,"slug":92},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":94,"show_sort_weight":95,"slug":96},"Technology",50,"technology",{"id":98,"doc_module":4,"doc_module_name":25,"category_name":99,"show_sort_weight":100,"slug":101},7,"Healthcare",40,"healthcare",{"id":103,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":104,"slug":105},8,30,"research-report",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},9,"Religion & Spirituality",20,"religion-spirituality",{"id":109,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":109,"slug":113},"World Cup","world-cup",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":115,"slug":117},10,"Lifestyle","lifestyle",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":89,"slug":121},19,"General","general",{"code":4,"msg":74,"data":123},{"doc_id":71,"user_id":124,"nickname":42,"user_avatar":125,"doc_module":4,"category_id":103,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":131,"language":132,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":12,"update_tm":136,"read_time":137,"preview_page_count":33,"preview_urls":138},7971474921005,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nFT-MDNNMDs: early detection of breast cancer using fine-tuned multi-deep neural networks with TCGA and clinical image datasets  \nArslan Shafique1􀀍, Abid Mehmood2, RabiahAl-Qudah2 & Khiati Zakaria2􀀍  \nBreast cancer remains one of the leading causes of cancer-related mortality among women worldwide. Early and accurate detection is critical for improving survival rates and enabling effective treatment. This research proposes a fine-tuned Multi-Deep Neural Network model with Multiple Datasets (FT  \nMDNNMDs). The proposed system employs a hierarchical classification strategy, first distinguishing cancer from normal cases, and subsequently classifying cancer-positive cases into Stage II and Stage III categories. The model integrates data from The Cancer Genome Atlas (TCGA) and a private clinical image dataset collected from hospitals in Pakistan. Preprocessing techniques, including image normalization, filtering, and Principal Component Analysis (PCA), are applied to enhance feature quality and reduce redundancy. Transfer learning and fine-tuning strategies are incorporated to further improve classification performance. The proposed model effectively distinguishes between benign and malignant tumors and accurately identifies stage II and stage III cases. Experimental results demonstrate that the fine-tuned MDNNMDs model achieves an accuracy of 99.57%, outperforming conventional machine learning algorithms such as Support Vector Machine (94.46%), Decision  \nTree (93.54%), and Naïve Bayes (91.22%). The model also achieved superior MCC (99.46%), F-score (99.57%), and recall (99.63%). In addition to algorithmic comparison, the performance of the proposed model is compared with existing breast cancer detection models, and it is revealed that the proposed model provides more accurate results than existing ones, with 1.5% to 3.0% better accuracy.  \nBreast cancer is a global health concern and is the second most common cause of cancer-related deaths among women worldwide1,2. It arises primarily in the breast lobules or ducts and can progress rapidly if not detected and treated in its earlier stages. According to recent statistics, breast cancer accounts for a significant percentage of new cancer diagnoses annually, and its incidence is increasing due to factors such as urbanisation, lifestyle changes, and lack of access to early screening in many parts of the world. Early and accurate detection of breast cancer is necessary because it can dramatically improve survival rates and treatment effectiveness. In particular, stages II and III of breast cancer represent more critical diagnostic window. At these stages, the tumor has typically begun to spread to nearby tissues or lymph nodes, but has not yet reached distant organs. Timely diagnosis at this point enables more aggressive and targeted treatment options. However, despite their clinical importance, stages II and III are often harder to detect reliably due to the subtlety of visual features and overlapping characteristics with benign tissue, especially in dense breast profiles3,4. Moreover, medical imaging techniques such as mammography, ultrasound, and magnetic resonance imaging (MRI) are widely used for breast cancer screening and diagnosis. However, each of these methods has its own limitations, such as reduced sensitivity in dense breast tissue, high false-positive rates, or limited accessibility and cost-effectiveness. Their diagnostic accuracy depends heavily on the expertise of the radiologist and the quality of the imaging equipment. Further, the interpretation of imaging results is often subjective; that leads to variability in diagnosis and the possibility of false positives or negatives5. Histopathological confirmation through biopsy is a very high standard, but it is invasive, time-consuming, and potentially associated with procedural risks such as the spread of malignant cells6.  \nIn response to th","cbCaiu6fkpFPHUYK","https://ap.wps.com/l/cbCaiu6fkpFPHUYK","pdf",8329427,23,"English","# Introduction\n## Breast cancer and the need for early detection\n## Clinical imaging methods and limitations\n## Motivation for AI and deep learning\n# Proposed FT-MDNNMDs framework\n## Hierarchical classification strategy\n## Datasets: TCGA and clinical images\n## Preprocessing and feature enhancement\n## Transfer learning and fine-tuning\n# Experimental results\n## Performance metrics and comparisons\n## Benchmarking against existing models","[{\"question\":\"How does FT-MDNNMDs perform compared with other methods?\",\"answer\":\"FT-MDNNMDs reports 99.57% accuracy and stronger metrics such as MCC, F-score, and recall, outperforming conventional machine learning baselines and existing breast cancer detection models by about 1.5% to 3.0% in accuracy.\"}]","FT-MDNNMDs - Early Detection of Breast Cancer Using Fine-Tuned Multi-Deep Neural Networks with TCGA and Clinical Image Datasets | PDF",1790109914,58,[139,143,147,151],{"page_no":22,"url":140,"width":141,"height":142},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/87706c4d8062cdb941c48e19aeed9315.webp",983,1291,{"page_no":26,"url":144,"width":145,"height":146},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ed063d3dea847c42b2ee1a247cf898c.webp",982,1290,{"page_no":30,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/42c1aa94b50cc31c091cb65425197113.webp",981,1289,{"page_no":33,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dbe74f86ecfb670b5dfaff8421ca1299.webp",980,1287]